Compounds > 2-piperidone
Page last updated: 2024-08-21

2-piperidone and Lymphoma

2-piperidone has been researched along with Lymphoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Aguilera, RJ; Contreras, L; Das, U; Dimmock, JR; Hossain, M; Penichet, ML; Swain, RM; Valenzuela, CA; Varela-Ramirez, A1
Fu, D; Jiang, ZY; Lin, QL; Liu, JB; Ma, YS; Wang, XF; Wu, TM; Xia, Q; Yu, F; Zhang, YJ1
Aguilera, RJ; Calderon, RI; Contreras, L; Das, U; Dimmock, JR; Quan, Y; Skouta, R; Varela-Ramirez, A; Zhang, HY1
Baráth, Z; Bata, Z; Das, U; Dimmock, JR; Molnár, J1

Other Studies

4 other study(ies) available for 2-piperidone and Lymphoma

ArticleYear
Two novel piperidones induce apoptosis and antiproliferative effects on human prostate and lymphoma cancer cell lines.
    Investigational new drugs, 2022, Volume: 40, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Humans; Lymphoma; Male; Piperidones; Prostate

2022
Inhibition of USP14 and UCH37 deubiquitinating activity by b-AP15 as a potential therapy for tumors with p53 deficiency.
    Signal transduction and targeted therapy, 2020, 04-01, Volume: 5, Issue:1

    Topics: Animals; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Lymphoma; Piperidones; Tumor Suppressor Protein p53; Ubiquitin Thiolesterase

2020
Induction of apoptosis via proteasome inhibition in leukemia/lymphoma cells by two potent piperidones.
    Cellular oncology (Dordrecht), 2018, Volume: 41, Issue:6

    Topics: Apoptosis; Cell Line, Tumor; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Gene Ontology; Humans; Inhibitory Concentration 50; Leukemia; Lymphoma; Molecular Weight; Neoplasm Proteins; Piperidones; Polyubiquitin; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Reproducibility of Results; Signal Transduction; Ubiquitinated Proteins; Unfolded Protein Response; Up-Regulation

2018
1-[4-(2-Aminoethoxy)phenylcarbonyl]-3,5-bis-(benzylidene)-4-oxopiperidines: a novel series of highly potent revertants of P-glycoprotein associated multidrug resistance.
    Bioorganic & medicinal chemistry letters, 2008, Jun-15, Volume: 18, Issue:12

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Lymphoma; Mice; Molecular Structure; Piperidones; Structure-Activity Relationship; Transfection

2008